Biotechnology Assets, S.A. 041.SG Stock
0.3 EUR
{{ price }}
8.791204%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Stuttgart
Market Cap
21.13M EUR
LOW - HIGH [24H]
0.27
-
0.3 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
5.93
Earnings per share
0.05 EUR
Biotechnology Assets, S.A. Price Chart
Biotechnology Assets, S.A. 041.SG Financial and Trading Overview
| Biotechnology Assets, S.A. stock price | 0.3 EUR |
| Previous Close | 0.3 EUR |
| Open | 0.3 EUR |
| Bid | 0.33 EUR x 150000 |
| Ask | 0.47 EUR x 150000 |
| Day's Range | 0.3 - 0.3 EUR |
| 52 Week Range | 0.001 - 0.56 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 22.02M EUR |
| Beta (5Y Monthly) | 1.472796 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.05 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 6, 2022 |
| 1y Target Est | N/A |
041.SG Valuation Measures
| Enterprise Value | 23.45M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.446154 |
| Price/Book (mrq) | 4.0675673 |
| Enterprise Value/Revenue | 7.927 |
| Enterprise Value/EBITDA | -32.971 |
Trading Information
Biotechnology Assets, S.A. Stock Price History
| Beta (5Y Monthly) | 1.472796 |
| 52-Week Change | 86.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.56 EUR |
| 52 Week Low | 0.001 EUR |
| 50-Day Moving Average | 0.32 EUR |
| 200-Day Moving Average | 0.21 EUR |
041.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 54.2M |
| Float | 28.73M |
| Short Ratio | N/A |
| % Held by Insiders | 49.24% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -65.70% |
| Operating Margin (ttm) | -58.70% |
| Gross Margin | 89.07% |
| EBITDA Margin | -24.041% |
Management Effectiveness
| Return on Assets (ttm) | -5.65% |
| Return on Equity (ttm) | -47.33% |
Income Statement
| Revenue (ttm) | 2.96M EUR |
| Revenue Per Share (ttm) | 0.06 EUR |
| Quarterly Revenue Growth (yoy) | -19.40% |
| Gross Profit (ttm) | 2.63M EUR |
| EBITDA | -711124 EUR |
| Net Income Avi to Common (ttm) | -1943364 EUR |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 800.4K EUR |
| Total Cash Per Share (mrq) | 0.02 EUR |
| Total Debt (mrq) | 8.25M EUR |
| Total Debt/Equity (mrq) | 212.89 EUR |
| Current Ratio (mrq) | 0.883 |
| Book Value Per Share (mrq) | 0.074 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17331 EUR |
| Levered Free Cash Flow (ttm) | -973921 EUR |
Profile of Biotechnology Assets, S.A.
| Country | Germany |
| State | N/A |
| City | Cádiz |
| Address | Av. del Desarrollo Tecnológico, 11 |
| ZIP | 11591 |
| Phone | 34 85 681 84 24 |
| Website | https://www.biatgroup.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 34 |
Biotechnologies Assets SA develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.
Q&A For Biotechnology Assets, S.A. Stock
What is a current 041.SG stock price?
Biotechnology Assets, S.A. 041.SG stock price today per share is 0.3 EUR.
How to purchase Biotechnology Assets, S.A. stock?
You can buy 041.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biotechnology Assets, S.A.?
The stock symbol or ticker of Biotechnology Assets, S.A. is 041.SG.
Which industry does the Biotechnology Assets, S.A. company belong to?
The Biotechnology Assets, S.A. industry is Biotechnology.
How many shares does Biotechnology Assets, S.A. have in circulation?
The max supply of Biotechnology Assets, S.A. shares is 71.14M.
What is Biotechnology Assets, S.A. Price to Earnings Ratio (PE Ratio)?
Biotechnology Assets, S.A. PE Ratio is 5.93999960 now.
What was Biotechnology Assets, S.A. earnings per share over the trailing 12 months (TTM)?
Biotechnology Assets, S.A. EPS is 0.05 EUR over the trailing 12 months.
Which sector does the Biotechnology Assets, S.A. company belong to?
The Biotechnology Assets, S.A. sector is Healthcare.